SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-004166
Filing Date
2022-03-18
Accepted
2022-03-18 16:24:26
Documents
12
Period of Report
2022-03-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K oncr-20220315.htm   iXBRL 8-K 46764
  Complete submission text file 0000950170-22-004166.txt   166826

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT oncr-20220315_pre.xml EX-101.PRE 10320
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT oncr-20220315.xsd EX-101.SCH 2480
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT oncr-20220315_lab.xml EX-101.LAB 13996
6 EXTRACTED XBRL INSTANCE DOCUMENT oncr-20220315_htm.xml XML 4882
Mailing Address 50 HAMPSHIRE STREET SUITE 401 CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET SUITE 401 CAMBRIDGE MA 02139 857-320-6400
Oncorus, Inc. (Filer) CIK: 0001671818 (see all company filings)

IRS No.: 473779757 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39575 | Film No.: 22752866
SIC: 2834 Pharmaceutical Preparations